THX Pharma

THX Pharma (formerly Theranexus), established in 2013, is a biopharmaceutical company developing drug candidates for the treatment of central nervous system (CNS) disorders. Starting with the observation of the effectiveness of current psychotropic drugs used for neurological conditions such as narcolepsy, Parkinson's disease, Alzheimer's disease, neuropathic pain, psychiatric disorders, epilepsy, and others, the company identified the development of new and more effective treatments as a significant unmet need. THX Pharma currently holds a unique position in the field of CNS disorder treatments, offering a therapeutic approach and proprietary technology aimed at addressing markets that have not been satisfactorily covered by the pharmaceutical industry to date.